Molly McLaughlin

Molly McLaughlin began their work experience in 2021 as a Manufacturing Associate at Moderna, where they were involved in the development of the mRNA Covid-19 vaccine. Molly operated in a large-scale drug manufacturing team and followed strict protocols and procedures. Molly collaborated with various departments to solve processing delays. In 2022, they joined ReCode Therapeutics as a Research Associate and continued in that role until 2023. Additionally, Molly joined Orbital Therapeutics in 2023 as a Research Associate II.

Molly McLaughlin attended the College of Charleston from 2017 to 2021, where they obtained a Bachelor of Science degree in Biology, with a field of study in General Biology. In addition to their degree, Molly earned a certification in Foundations of GMP from USP education in May 2023.